Page last updated: 2024-08-21

hematoporphyrin and imiquimod

hematoporphyrin has been researched along with imiquimod in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Chen, Y; Guo, L; Liu, C; Ren, W; Sun, L; Xu, H; Yin, H; Yu, L; Yue, W; Zhang, K; Zhang, Y; Zhou, B	1

Other Studies

1 other study(ies) available for hematoporphyrin and imiquimod

Article	Year
Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice. Nature communications, 2019, 05-02, Volume: 10, Issue:1 Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Immunological; Apoptosis; B7-H1 Antigen; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Hematoporphyrins; Humans; Imiquimod; Immunotherapy; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasms; Treatment Outcome; Ultrasonic Therapy	2019

Article

Year

Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.

Nature communications, 2019, 05-02, Volume: 10, Issue:1

Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Immunological; Apoptosis; B7-H1 Antigen; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Hematoporphyrins; Humans; Imiquimod; Immunotherapy; Liposomes; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Neoplasms; Treatment Outcome; Ultrasonic Therapy

2019